• Accueil >
  • Publications >
  • ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics

16 janv. 2020Oncogene

DOI : 10.1038/s41388-019-1001-5

Auteurs

Nicolas Kiavue, Luc Cabel, Samia Melaabi, Guillaume Bataillon, Celine Callens, Florence Lerebours, Jean-Yves Pierga, Francois-Clement Bidard